Interaction of human plasma membrane proteins and oligodeoxynucleotides

Area of Science:

• Molecular Biology
• Biochemistry
• Cell Biology

Background:

• Two novel oligodeoxynucleotide (oligodN) binding proteins (100-110 kDa) were previously identified on human plasma membranes.
• These proteins are implicated in the cellular uptake of oligodeoxynucleotides.

Purpose of the Study:

• To investigate how oligodeoxynucleotide (oligodN) chain length and sequence affect their interaction with identified plasma membrane proteins.
• To elucidate the specific binding requirements and kinetics of oligodeoxynucleotide-protein interactions.

Main Methods:

• Investigated the impact of varying oligodeoxynucleotide (oligodN) chain lengths on protein binding.
• Analyzed the influence of oligodeoxynucleotide (oligodN) base composition and sequence on binding affinity.
• Examined binding kinetics using homopolymers of deoxycytidine (dC21) and deoxythymidine (dT21).

Main Results:

• Oligodeoxynucleotide (oligodN) chain length is a significant, but not the sole, factor in protein interaction.
• Pyrimidine bases (thymine and cytosine) are crucial for high-affinity binding, while purine bases are not.
• Binding kinetics suggest distinct protein binding sites, one favoring thymine and the other cytosine.
• Additional plasma membrane proteins (40-58 kDa) were identified that bind thymine but not cytosine.

Conclusions:

• Oligodeoxynucleotide (oligodN) binding to plasma membrane proteins is sequence-dependent, with a preference for pyrimidines.
• The identified proteins likely possess distinct binding pockets for different nucleotide bases, influencing oligodeoxynucleotide (oligodN) uptake.
• Further characterization of these binding proteins could inform the development of oligonucleotide-based therapeutics.